Jobs makes info about his health a trade secret

Jan 18, 2011 By MARILYNN MARCHIONE , AP Medical Writer
Three file photos, from left, Jan. 2010, July 2010 and Oct. 2010, show Apple CEO Steve Jobs. Apple announced Monday Jan. 17, 2011, that Jobs is taking a medical leave of absence for the second time in two years. (AP Photo/Paul Sakuma/file)

(AP) -- It would be easier to gauge Apple CEO Steve Jobs' current medical problems if he had said more about the ones he has faced in the past.

Jobs, who turns 56 next month, said Monday that he would take a third leave of absence - he didn't say how long - to focus on his health. It may not be as serious as many fear, but coming from a man who has had cancer and a liver transplant, the lack of detail is causing concern.

Jobs had a neuroendocrine tumor removed in 2004 - a rare and very treatable form of pancreatic cancer - but never said if it had spread to or how extensive his surgery was.

"We don't really know how much of his pancreas was removed. He may just have a remnant," and that may be causing continued digestive difficulties, said Dr. Charles R. Thomas of the Ohio State University's Knight Cancer Institute.

Nor has Jobs revealed why he had a in the spring of 2009. It could have been for an unrelated problem, but some experts not involved in his treatment speculated that his cancer had spread.

"These tumors are notorious for recurrence. It may take many years for them to reappear" because they grow so slowly, said Dr. Igor Astsaturov of Fox Chase Cancer Center in Philadelphia.

Since the transplant, Jobs has remained extremely thin and has not appeared at recent events.

"If he's jaundiced, there's a concern the liver may not be working as well as it should," Thomas said. Fatigue and weight loss also are troubling signs, he said.

Jobs could be suffering side effects from immune-suppressing medicines to prevent . Even if his cancer has recurred, there are many treatment options, including chemotherapy and newer drugs that target various cancer pathways.

"It would be reasonable to consider surgery" or another procedure to destroy small tumors if the cancer turned up in his new liver, Thomas said. "They may be ready to do some aggressive intervention to get him back in the ballgame."

Dr. Jennifer Obel, a spokeswoman for the American Society of Clinical Oncology and a cancer specialist at Northshore University Health System in suburban Chicago, said the prognosis is good for those with pancreatic tumors like the one Jobs had, even if they spread.

"He's done extremely well living with this disease for many years," she said. "I wouldn't assume anything until he has released more information."

Explore further: HP sales inch up while profit drops

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Apple CEO gets liver transplant: report

Jun 20, 2009

Apple chief executive Steve Jobs, on medical leave since January for treatment of an undisclosed condition, received a liver transplant about two months ago in Tennessee, The Wall Street Journal reported ...

Jobs appears closer to returning to work at Apple

Jun 24, 2009

(AP) -- Apple co-founder and CEO Steve Jobs appears to be a step closer to returning to work, as a doctor gave him an "excellent prognosis" after receiving a liver transplant at a Tennessee hospital.

Recommended for you

Ticketfly buying WillCall for on-premise data

8 hours ago

Ticketfly Inc., a San Francisco-based technology company among several posing a challenge to Ticketmaster, is acquiring WillCall Inc., a crosstown rival that turns your smartphone into a mobile wallet at live events.

HP revenue inches up after years of decline

23 hours ago

Hewlett-Packard on Wednesday reported that its quarterly revenue rose for the first time in three years, nudged by improved computer sales everywhere except Russia and China.

Restaurants experimenting with pay-in-advance tickets

Aug 20, 2014

With restaurant patrons increasingly jumping on the Internet to make reservations, some high-end eateries here and across the country are adding a new tech wrinkle: having their clientele pay for their meal in advance using ...

Chip maker Infineon to buy California firm for $3B (Update)

Aug 20, 2014

German chip maker Infineon Technologies AG says it has agreed to pay $3 billion in cash for California-based semiconductor firm International Rectifier, which produces power-management components used in everything from cars ...

User comments : 0